MedPath

Reproducibility of fNIRS Parameters During Walking

Not Applicable
Completed
Conditions
Stroke
Interventions
Procedure: Functional Near-Infrared Spectroscopy (fNIRS)
Registration Number
NCT04882930
Lead Sponsor
Centre Hospitalier Régional d'Orléans
Brief Summary

Brain activation can be studied using the Functional Near InfraRed Spectroscopy (fNIRS). It was shown that CPF activation during walking and during dual task could be different in stroke patients and in healthy subjects.

To date, fNIRS reliability is not completely established during walking and during dual task. Therefore, this study will examine the reproducibility of fNIRS parameters during simple walking and during dual task in healthy subjects and in stroke patients.

Detailed Description

A fNIRS system will be used to measure the CPF activation. The subjects will walk at their preferred speed on 10 m 3 times and while doing a cognitive task (dual task) 3 times also (in a random order). The same test will be repeated five minutes later. The fNIRS system will be retired and the same test will be repeated 10 min later.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Acute stroke group, subacute stroke group, and control group:

    • Age 50 to 80 years
    • Affiliated with a social security plan
    • Able to walk 20 meters unassisted
  • Acute Stroke and Subacute Stroke Group:

    • Stroke onset less than 14 days (for the acute stroke group) or between 14 days and 6 months (for the subacute stroke group)
    • Stroke located in the left or right middle cerebral artery.
Read More
Exclusion Criteria
  • Acute stroke group, subacute stroke group, and control group:

    • Person under guardianship or curatorship
    • Refusal to sign informed consent
    • Known rheumatologic or cardiologic history
    • Medication that alters the vigilance and may affect walking (high dose psychotropic drugs, antispastic drugs).
  • Acute stroke group and subacute stroke group:

    • History of symptomatic stroke
    • Previous neurological disease limiting gait, aphasia or impaired cognitive function (mild cognitive dementia, Alzheimer's or Parkinson's disease)
    • Ambulatory functional category < 3
  • Control group: neurological medical history

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Functional Near-Infrared Spectroscopy (fNIRS) acquisitionsFunctional Near-Infrared Spectroscopy (fNIRS)The hemodynamic response in CPF will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.
Primary Outcome Measures
NameTimeMethod
Oxyhemoglobin (HbO) variations during simple walking and during dual taskDay 0

HbO will be measured by the NIR spectrometry technique continuously at rest and during walking. This technique allows to measure the variations of HbO concentration by measuring the variations of light absorption by the explored tissues.

Deoxyhemoglobin (HbR) variations during simple walking and during dual taskDay 0

HbR will be measured by the NIR spectrometry technique continuously at rest and during walking. This technique allows to measure the variations of HbR concentration by measuring the variations of light absorption by the explored tissues.

Secondary Outcome Measures
NameTimeMethod
Oxyhemoglobin (HbO) variations of acute stroke patientsDay 0
Oxyhemoglobin (HbO) variations using different mathematical treatments.Day 0
Deoxyhemoglobin (HbR) variations of acute stroke patientsDay 0
Deoxyhemoglobin (HbR) variations of subacute stroke patientsDay 0
Oxyhemoglobin (HbO) variations of subacute stroke patientsDay 0
Deoxyhemoglobin (HbR) variations using different mathematical treatments.Day 0

Trial Locations

Locations (3)

Centre de Réadaptation Fonctionnelle et d'Appareillage Le Coteau

🇫🇷

La Chapelle-Saint-Mesmin, France

Chu Limoges

🇫🇷

Limoges, France

CHR Orléans

🇫🇷

Orléans, France

© Copyright 2025. All Rights Reserved by MedPath